Cargando…
Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies
Alterations to the EGFR (epidermal growth factor receptor) gene, which primarily occur in the axon 18–21 position, have been linked to a variety of cancers, including ovarian, breast, colon, and lung cancer. The use of TK inhibitors (gefitinib, erlotinib, lapatinib, and afatinib) and monoclonal anti...
Autores principales: | Opo, F A Dain Md, Moulay, Mohammed, Zari, Ali, Alqaderi, Afnan, Alkarim, Saleh, Zari, Talal, Bhuiyan, Mohiuddin Ahmed, Mahmoud, Maged Mostafa, Aljoud, Fadwa, Suhail, Mohd, Edris, Sherif, Ramadan, Wafaa S., Kamal, Mohammad Amjad, Nemmiche, Saïd, Ahammad, Foysal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707641/ https://www.ncbi.nlm.nih.gov/pubmed/36457709 http://dx.doi.org/10.3389/fphar.2022.1027890 |
Ejemplares similares
-
Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein
por: Opo, Firoz A. Dain Md, et al.
Publicado: (2021) -
Author Correction: Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein
por: Opo, Firoz A. Dain Md, et al.
Publicado: (2021) -
Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma
por: Opo, F A Dain Md, et al.
Publicado: (2022) -
Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1
por: Molla, Mohammad Habibur Rahman, et al.
Publicado: (2023) -
Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process
por: Dain Md Opo, F. A., et al.
Publicado: (2022)